Investor · 1 deal
Perth, WA
Every published round Sixty Two Capital took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Emyria | Unnamed stage | 1 May 2023 | $2.5m | Lead | Startup Daily, Tenmile portfolio |
Companies Sixty Two Capital has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Emyria | 1 May 2023 | 1 | 1 |
Fund closes reported for Sixty Two Capital, as distinct from the investments it has made.
Companies Sixty Two Capital has backed that another company then bought. An exit for the holding, not a deal Sixty Two Capital did.
Stories naming Sixty Two Capital. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Therapeutic psychedelics biotech Emyria has banked $2.5 million via a share placement co-led by Sixty Two Capital and Taylor Collison, with follow-on from Andrew Forrest's Tenmile, funding MDMA- and psilocybin-assisted therapy and cannabinoid trials.